REG - Syncona Limited - Transaction in Own Shares

SynconaAnnouncement

18/12/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231218:nRSR0629Xa&default-theme=true

RNS Number : 0629X  Syncona Limited  18 December 2023

18 December 2023

Syncona Limited

("Syncona" or the "Company")

Transaction in Own Shares

Syncona, a leading healthcare company focused on creating, building and
scaling global leaders in life science announces that, in accordance with the
terms of its share buyback programme announced on 29 September 2023 (the
"Share Buyback Programme"), the Company purchased the following number of its
ordinary shares of no par value ("Ordinary Shares") each through Numis
Securities Limited ("Numis").

 Date of purchase:                                    15 December 2023
 Aggregate number of Ordinary Shares purchased:       34,268
 Lowest price paid per share (GBp):                   117.98
 Highest price paid per share (GBp):                  117.98
 Volume weighted average price paid per share (GBp):  117.98

 

The repurchased Ordinary Shares will be held by the Company in treasury.
Following the purchase and settlement of these Ordinary Shares, the Company's
issued ordinary share capital is 671,806,666 of which 6,711,779 Ordinary
Shares will be held in treasury, which attract no voting rights. Therefore,
the total voting rights in the Company will be 665,094,887. This figure for
the total number of voting rights may be used by shareholders as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No. 596/2014 which forms
part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018,
the table below contains detailed information of the individual trades made by
Numis as part of the Share Buyback Programme.

 

Individual information:

 

 Numbers of shares purchased  Transaction price (pence per share)  Time of transaction  Venue
 34,268                       117.98                               16:41.58             XLON

 

Corrections to the Total Voting Rights and Total Treasury Shares figures from
announcements released on 4-14 December 2023 (inclusive) are listed below. All
other information was correct:

 RNS number  Date of purchase  Date of announcement  Shares purchased  Total Voting Rights  Total Treasury Shares
 4692V       01/12/2023        04/12/2023            75,275            666,469,155          5,337,511
 6299V       04/12/2023        05/12/2023            160,000           666,309,155          5,497,511
 7789V       05/12/2023        06/12/2023            160,000           666,149,155          5,657,511
 9366V       06/12/2023        07/12/2023            160,000           665,989,155          5,817,511
 0904W       07/12/2023        08/12/2023            160,000           665,829,155          5,977,511
 2358W       08/12/2023        11/12/2023            160,000           665,669,155          6,137,511
 3962W       11/12/2023        12/12/2023            160,000           665,509,155          6,297,511
 5469W       12/12/2023        13/12/2023            160,000           665,349,155          6,457,511
 7001W       13/12/2023        14/12/2023            60,000            665,289,155          6,517,511

 

For further information, please contact:

Syncona Ltd

Annabel Clark

Tel: +44 (0) 7714 916615

 

Numis Securities Limited

Nathan Brown

Freddie Barnfield

Tel: +44 (0) 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSTFBMTMTABTTJ